(R)-Fmoc-4-amino-5-(3-indolyl)pentanoic acid, 95+%, 100mg

4-Bromo-2,5-difluorobenzaldehyde, 95.0%, 100g

Ethyl 5-(3,4-difluorophenyl)-3-methyl-1H-pyrrole-2-carboxylate, 97.0%, 250mg

tert-Butyl (3-aminopyridin-2-yl)carbamate, 95.0%, 100mg

5-Methyl-1H-indazol-6-ol, 95.0%, 1g

GC capillary column ROTI®Cap-1, 60 m, 0.25 mm, 1.00 µm, 1 Piece(s)

2-Cyclohexylethylamine>98.0%(GC)(T)1g

(4S,4'S)-2,2'-(1,3-BIS(4-(TERT-BUTYL)PHENYL)PROPANE-2,2-DIYL)BIS(4-ISOPROPYL-4,5-DIHYDROOXAZOLE), 95%, 1g

3-bromo-4-chloro-1-[(4-methoxyphenyl)methyl]-1H-pyrazolo[3,4-b]pyridine, 97.0%, 5g

1-Ethynyl-4-fluoro-2-(trifluoromethyl)benzene, 95+%, 1g

Roquinimex, 96%, 100mg

2-Amino-benzo[b]thiophene-3-carboxylic acid ethyl ester, 95.0%, 1g

2-Chloro-3-methoxy-6-nitroaniline, 98%, 5g